Area pharmaceutical companies BioClinica and Novo Nordisk both said this week they are growing in what they do best.
BioClinica, which is based in Newtown, Bucks County, is a contract research organization (CRO) which means it administers clinical trials all over the globe for drug companies.
BioClinica said revenues increased from $16.9 million to $19.1 million (an increase of 12.8 percent) as compared with the same period in 2011. Using GAAP formula, BioClinica said its profit rose from $924,000 to $1 million for the same period.
The link to the BioClinica press release and report is here.
Novo Nordisk is based in Denmark, but has a big operation in Princeton and is perhaps an outsized player in the huge space of diabetes care.
Reuters reported that Novo predicts full-year sales growth of 9 to 12 percent, versus the previous forecast range of 8 to 11 percent, using local currencies. Novo also predicted operating profits of 15 percent for the year.
The link to the Reuters story is here.